Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01345058 · ClinicalTrials.gov registry record · Phase 3
Add on Lacosamide Versus High Dose Monotherapy
A Phase 3 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 56
- Enrollment target
NCT01345058 is a Phase 3 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 56 participants.
The verdict
NCT01345058, a Phase 3 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 56 participants
- Enrollment target
Study Summary
This is a study to determine whether a combination of low dose lacosamide and levetiracetam is more effective than high dose levetiracetam in patients who have failed low dose levetiracetam.
Interventions
- DRUG levetiracetam
- DRUG lacosamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2011-08-01 |
| Est. Completion | 2014-10-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01345058
The ClinicalTrials.gov registry entry for NCT01345058 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which levetiracetam is the first listed.
NCT01345058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01345058 about?
NCT01345058 is a clinical study titled "Add on Lacosamide Versus High Dose Monotherapy". This is a study to determine whether a combination of low dose lacosamide and levetiracetam is more effective than high dose levetiracetam in patients who have failed low dose levetiracetam.
What is the current status of trial NCT01345058?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 56 participants. The study started on 2011-08-01. Estimated completion is 2014-10-21.
What interventions are being tested in trial NCT01345058?
The interventions under investigation include: levetiracetam (DRUG), lacosamide (DRUG).
Who is sponsoring clinical trial NCT01345058?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.